We anticipate our collaboration with TD2 will enable Avantra to expedite the launch of new oncology concentrated QPDx BioChip panels, and enable TD2 to few advanced multiplex protein technology making use of their innovative drug profiling system. .. Avantra Biosciences selects TGen Medication Advancement for new biomarker quantitation platform Avantra Biosciences today announced selecting TGen Drug Advancement as an integral check site for Avantra’s brand-new biomarker quantitation system. Avantra, structured near Boston in Woburn, Mass., has generated an automated multiplex immunoassay program to judge the associations between elevated proteins levels, unique patient features, and medication responses... Anthem Blue Cross to get Tri-County Business contract renewal award Anthem Blue Cross announced today that the California Department of Health Care Providers intends to award Anthem the Tri-County Commercial contract renewal to supply Medi-Cal benefits to citizens in the Fresno, Madera and Kings Counties. This award is the second largest expansion and the 3rd largest renewal in the country this year. The award of this contract enables Anthem Blue Cross’ State Sponsored Business to keep to deliver on the promise designed to occupants in the Central Valley 13 years ago, stated Kevin Hayden, president, State Sponsored Business.